| A case of twin pregnancy with complete hydatidiform mole and coexisting fetus following IVF-ET. | |
| | |
MedLine Citation:
|
PMID: 12005310 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Twin pregnancy consisting of complete hydatidiform mole (H-mole) and a coexisting fetus occurs with an estimated incidence of 1 per 22,000-100,000 pregnancies. The incidence of this unusual twin pregnancy with complete H-mole and a coexisting fetus after in vitro fertilization and embryo transfer (IVF-ET) is not thought to be greater than that of general population. We present an unusual twin pregnancy with complete H-mole and a coexisting fetus that occurred following IVF-ET, which was terminated at 21 weeks of gestation and developed into nonmetastatic gestational trophoblastic tumor. |
| | |
Authors:
|
Hye-Eun Kwon; Eun-Joo Park; Sung-Hoon Kim; Hee-Dong Chae; Hye-Sung Won; Chung-Hoon Kim; Byung-Moon Kang |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of assisted reproduction and genetics Volume: 19 ISSN: 1058-0468 ISO Abbreviation: J. Assist. Reprod. Genet. Publication Date: 2002 Mar |
Date Detail:
|
Created Date: 2002-05-13 Completed Date: 2002-12-09 Revised Date: 2013-03-21 |
Medline Journal Info:
|
Nlm Unique ID: 9206495 Medline TA: J Assist Reprod Genet Country: United States |
Other Details:
|
Languages: eng Pagination: 144-8 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Songpa-Gu, Seoul, South Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Abortion, Therapeutic Abortion, Threatened / etiology Adult Antimetabolites, Antineoplastic / adverse effects, therapeutic use Chorionic Gonadotropin, beta Subunit, Human / blood Combined Modality Therapy Embryo Transfer* Female Fertilization in Vitro* Humans Hydatidiform Mole* / drug therapy, therapy Infant, Newborn Leucovorin / therapeutic use Male Methotrexate / adverse effects, therapeutic use Pregnancy Pregnancy Complications, Neoplastic* Pregnancy, Multiple* Tumor Markers, Biological / blood Uterine Hemorrhage / etiology Uterine Neoplasms* / drug therapy, therapy |
| Chemical | |
Reg. No./Substance:
|
0/Antimetabolites, Antineoplastic; 0/Chorionic Gonadotropin, beta Subunit, Human; 0/Tumor Markers, Biological; 58-05-9/Leucovorin; 59-05-2/Methotrexate |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Protein supplementation of human IVF culture media.
Next Document: Birth of a healthy male after frozen thawed blastocyst transfer following intracytoplasmic injection...